About
Cristina Campero is the founder and CEO of PROSPERiA, a company developing AI-based diagnostics for chronic diseases, with an initial focus on preventing blindness in Mexico and Latin America. She previously worked at McKinsey & Company and at Wren Therapeutics, a healthtech company in the UK. Campero holds an MPhil from the University of Cambridge.
Experience
- PROSPERiAFoundercurrent2020 — present
- PROSPERiAChief Executive Officercurrent2020 — presentMexico City, Mexico
- retinIAChief Executive Officercurrent2020 — present
- AmelaMember — Amelacurrent2025 — present
- McKinsey & CompanyAssociate2018 — 2020Mexico City Area, Mexico
- Wren Therapeutics LtdAssociate2017 — 2018Cambridge, United Kingdom
- Malin Corporation plcInternship2017Cambridge, United Kingdom
- McKinsey & CompanyBusiness Analyst2014 — 2016Mexico City
Skills & more
Microsoft Office17Business Strategy25Microsoft Excel9Strategic PlanningProject Management9Management Consulting11StrategyResearch2
- Miembro oficial de la Asociación HealthTech de México - AZ — Asociación HealthTech México
From Cristina's professional profile.
Colleagues at Lotux Ventures
Adeo Ressi
Partner at Founder Capital
Alex Romero
Investor at Lotux Ventures
Chiara Sheldon
Investor at Lotux Ventures
Dan Melendez
Investor at Lotux Ventures
Diego Muradas
Investor at Lotux Ventures
Ivonne Quiñones
Investor at Lotux Ventures
Jan Heinvirta
Investor at Lotux Ventures
Martin Haiek
Investor at Lotux Ventures
Frequently asked questions
- Who is Cristina Campero?
- Cristina Campero is the founder and CEO of PROSPERiA, a company developing AI-based diagnostics for chronic diseases, with an initial focus on preventing blindness in Mexico and Latin America. She previously worked at McKinsey & Company and at Wren Therapeutics, a healthtech company in the UK. Campero holds an MPhil from the University of Cambridge.
- Where does Cristina Campero work?
- Cristina Campero is at Lotux Ventures.
- Where did Cristina Campero go to school?
- Cristina Campero studied at University of Cambridge (Master of Philosophy (M.Phil.), Bioscience Enterprise); Universidad Nacional Autónoma de México (Bachelor's degree, Biochemistry and Pharmaceutical Science).
Same school
Also attended University of Cambridge893
Stewart ButterfieldCo-founder of Slack and FlickrDemis HassabisCo-founder & CEO of Google DeepMindNiko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray Ventures
.png)
+ 887 more
Also attended Universidad Nacional Autónoma de México24
Tomosaku SoharaGeneral Partner at NordicNinjaJuan FigueroaLead Backend Engineer at Struck CapitalRodolfo GonzalezGeneral Partner at Foundation CapitalVioleta ChávezAccountant at Discovery AmericasWilber PalenquePrincipal at Avalancha VenturesSarah CarrFund Manager at Big Red Ventures
+ 18 more
Shared employers
Also worked at Amela2
Also worked at McKinsey & Company1,549
Elad GilSolo general partner investing through Gil CapitalJim BreyerFounder & CEO of Breyer CapitalAnn Miura-KoCo-founding Partner at FloodgateJeremy LiewPartner at Lightspeed Venture PartnersMike SpeiserManaging Director at Sutter Hill VenturesJeremy LevinePartner at Bessemer Venture Partners
+ 1,543 more
